Azithromycin and Ciprofloxacin Resistance in Salmonella Bloodstream Infections in Cambodian Adults

PLoS Neglected Tropical Diseases

Volumn 6, Issue 12, 2012, Pages

  Vlieghe, Erika R ^a   Phe, Thong ^b   de Smet, Birgit ^a   Veng, Chhun H ^b   Kham, Chun ^b   Bertrand, Sophie ^c   Vanhoof, Raymond ^c   Lynen, Lut ^a   Peetermans, Willy E ^d   Jacobs, Jan A ^a  

^a INSTITUTE OF TROPICAL MEDICINE   (Belgium)

^b Sihanouk Hospital Centre of Hope (SHCH)   (Cambodia)

^c SCIENTIFIC INSTITUTE OF PUBLIC HEALTH   (Belgium)

^d UNIVERSITY HOSPITALS LEUVEN   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; ANTIRETROVIRUS AGENT; AZITHROMYCIN; CEFOTAXIME; CEFTRIAXONE; CIPROFLOXACIN; COTRIMOXAZOLE; DNA TOPOISOMERASE (ATP HYDROLYSING); DNA TOPOISOMERASE IV; FLUCONAZOLE; FOSFOMYCIN; MEROPENEM; QUINOLINE DERIVED ANTIINFECTIVE AGENT; TIGECYCLINE; TUBERCULOSTATIC AGENT;

ADOLESCENT; ADULT; AGED; ANTIBIOTIC SENSITIVITY; ARTICLE; BLOOD CULTURE; BLOODSTREAM INFECTION; CHILD; FEMALE; GENE MUTATION; GENE SEQUENCE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; MINIMUM INHIBITORY CONCENTRATION; MULTIDRUG RESISTANCE; POLYMERASE CHAIN REACTION; PULSED FIELD GEL ELECTROPHORESIS; RECURRENT INFECTION; SALMONELLOSIS; SCHOOL CHILD;

ADOLESCENT; ADULT; AGED; ANTI-BACTERIAL AGENTS; AZITHROMYCIN; BACTEREMIA; CAMBODIA; CHILD; CIPROFLOXACIN; DRUG RESISTANCE, BACTERIAL; ELECTROPHORESIS, GEL, PULSED-FIELD; FEMALE; HUMANS; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; MOLECULAR TYPING; POLYMERASE CHAIN REACTION; PREVALENCE; SALMONELLA ENTERICA; SALMONELLA INFECTIONS; SEQUENCE ANALYSIS, DNA; YOUNG ADULT;

EID: 84872045406     PISSN: 19352727     EISSN: 19352735     Source Type: Journal    
DOI: 10.1371/journal.pntd.0001933     Document Type: Article

References (44)

1. Crump JA, Luby SP, Mintz ED, (2004) The global burden of typhoid fever. Bull World Health Organ 82: 346-353.
2. Crump JA, Mintz ED, (2010) Global trends in typhoid and paratyphoid Fever. Clin Infect Dis 50: 241-246.
3. Morpeth SC, Ramadhani HO, Crump JA, (2009) Invasive non-Typhi Salmonella disease in Africa. Clin Infect Dis 49: 606-611.
4. Reddy EA, Shaw AV, Crump JA, (2010) Community-acquired bloodstream infections in Africa: a systematic review and meta-analysis. Lancet Infect Dis 10: 417-432 S1473-3099(10)70072-4 [pii];10.1016/S1473-3099(10)70072-4 [doi].
5. Basnyat B, Maskey AP, Zimmerman MD, Murdoch DR, (2005) Enteric (typhoid) fever in travelers. Clin Infect Dis 41: 1467-1472.
6. Parry CM, Threlfall EJ, (2008) Antimicrobial resistance in typhoidal and nontyphoidal salmonellae. Curr Opin Infect Dis 21: 531-538.
7. Su LH, Chiu CH, Chu C, Ou JT, (2004) Antimicrobial resistance in nontyphoid Salmonella serotypes: a global challenge. Clin Infect Dis 39: 546-551.
8. Effa EE, Bukirwa H, (2008) Azithromycin for treating uncomplicated typhoid and paratyphoid fever (enteric fever). Cochrane Database Syst Rev CD006083.
9. Frenck RW Jr, Mansour A, Nakhla I, Sultan Y, Putnam S, et al. (2004) Short-course azithromycin for the treatment of uncomplicated typhoid fever in children and adolescents. Clin Infect Dis 38: 951-957.
10. Parry CM, Ho VA, Phuong LT, Bay PV, Lanh MN, et al. (2007) Randomized controlled comparison of ofloxacin, azithromycin, and an ofloxacin-azithromycin combination for treatment of multidrug-resistant and nalidixic acid-resistant typhoid fever. Antimicrob Agents Chemother 51: 819-825.
11. Levy MM, Fink MP, Marshall JC, Abraham E, Angus D, et al. (2003) 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. Crit Care Med 31: 1250-1256 10.1097/01.CCM.0000050454.01978.3B [doi].
12. Grimont PAD aWF-X2 (2007) Antigenic Formulae of the Salmonella Serovars (9th edition).
13. CDC (2012) PulseNet. http://www.cdc.gov/pulsenet/.
14. Tenover FC, Arbeit RD, Goering RV, Mickelsen PA, Murray BE, et al. (1995) Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J Clin Microbiol 33: 2233-2239.
15. CLSI (1-1-2012) CLSI M100-S22. Performance Standards for Antimicrobial Susceptibility Testing; Twenty-second Informational Supplement. CLSI document M100-S22. Clinical and Laboratory Standards Institute. ISBN: 1562387162. 28[1]. 1-1-2010. Wayne, PA: Clinical and Laboratory Standards Institute.
16. EUCAST (2012) European Committee on Antimicrobial Susceptibility Testing Breakpoint tables for interpretation of MICs and zone diameters. Version 1.3, January 5, 2011.
17. Sjolund-Karlsson M, Joyce K, Blickenstaff K, Ball T, Haro J, et al. (2011) Antimicrobial susceptibility to azithromycin among Salmonella enterica isolates from the United States. Antimicrob Agents Chemother 55: 3985-3989.
18. Endimiani A, Hujer AM, Hujer KM, Gatta JA, Schriver AC, et al. (2010) Evaluation of a commercial microarray system for detection of SHV-, TEM-, CTX-M-, and KPC-type beta-lactamase genes in Gram-negative isolates. J Clin Microbiol 48: 2618-2622 JCM.00568-10 [pii];10.1128/JCM.00568-10 [doi].
19. Griggs DJ, Gensberg K, Piddock LJ, (1996) Mutations in gyrA gene of quinolone-resistant Salmonella serotypes isolated from humans and animals. Antimicrob Agents Chemother 40: 1009-1013.
20. Cavaco LM, Hasman H, Xia S, Aarestrup FM, (2009) qnrD, a novel gene conferring transferable quinolone resistance in Salmonella enterica serovar Kentucky and Bovismorbificans strains of human origin. Antimicrob Agents Chemother 53: 603-608.
21. Kasper MR, Sokhal B, Blair PJ, Wierzba TF, Putnam SD, (2010) Emergence of multidrug-resistant Salmonella enterica serovar Typhi with reduced susceptibility to fluoroquinolones in Cambodia. Diagn Microbiol Infect Dis 66: 207-209 S0732-8893(09)00365-4 [pii];10.1016/j.diagmicrobio.2009.09.002 [doi].
22. Ochiai RL, Acosta CJ, Novaro-Holliday MC, Baiqing D, Bhattacharya SK, et al. (2008) A study of typhoid fever in five Asian countries: disease burden and implications for controls. Bull World Health Organ 86: 260-268.
23. Chau TT, Campbell JI, Galindo CM, Van Minh HN, Diep TS, et al. (2007) Antimicrobial drug resistance of Salmonella enterica serovar typhi in asia and molecular mechanism of reduced susceptibility to the fluoroquinolones. Antimicrob Agents Chemother 51: 4315-4323 AAC.00294-07 [pii];10.1128/AAC.00294-07 [doi].
24. WHO (2012) Cambodia Health Profile. http://www.who.int/gho/countries/khm.pdf.
25. Kingdom of Cambodia, Ministry of Health (1-1-1999) Clinical and Therapeutic Guideline for Referral Hospitals. Second edition, November 1999.
26. Parry CM, Vinh H, Chinh NT, Wain J, Campbell JI, et al. (2011) The influence of reduced susceptibility to fluoroquinolones in Salmonella enterica serovar Typhi on the clinical response to ofloxacin therapy. PLoS Negl Trop Dis 5: e1163 10.1371/journal.pntd.0001163 [doi];PNTD-D-10-00171 [pii].
27. Arjyal A, Basnyat B, Koirala S, Karkey A, Dongol S, et al. (2011) Gatifloxacin versus chloramphenicol for uncomplicated enteric fever: an open-label, randomised, controlled trial. Lancet Infect Dis 11: 445-454 S1473-3099(11)70089-5 [pii];10.1016/S1473-3099(11)70089-5 [doi].
28. Dolecek C, Tran TP, Nguyen NR, Le TP, Ha V, et al. (2008) A multi-center randomised controlled trial of gatifloxacin versus azithromycin for the treatment of uncomplicated typhoid fever in children and adults in Vietnam. PLoS One 3: e2188.
29. Chiu CH, Su LH, Chu C, (2004) Salmonella enterica serotype Choleraesuis: epidemiology, pathogenesis, clinical disease, and treatment. Clin Microbiol Rev 17: 311-322.
30. Hendriksen RS, Bangtrakulnonth A, Pulsrikarn C, Pornruangwong S, Noppornphan G, et al. (2009) Risk factors and epidemiology of the ten most common Salmonella serovars from patients in Thailand: 2002-2007. Foodborne Pathog Dis 6: 1009-1019.
31. Yodprom R, Pathanapitoon K, Kunavisarut P, Ausayakhun S, Wattananikorn S, et al. (2007) Endogenous endophthalmitis due to Salmonella choleraesuis in an HIV-positive patient. Ocul Immunol Inflamm 15: 135-138.
32. Hsueh PR, Teng LJ, Tseng SP, Chang CF, Wan JH, et al. (2004) Ciprofloxacin-resistant Salmonella enterica Typhimurium and Choleraesuis from pigs to humans, Taiwan. Emerg Infect Dis 10: 60-68.
33. Gordon MA, Banda HT, Gondwe M, Gordon SB, Boeree MJ, et al. (2002) Non-typhoidal salmonella bacteraemia among HIV-infected Malawian adults: high mortality and frequent recrudescence. AIDS 16: 1633-1641.
34. Chinh NT, Parry CM, Ly NT, Ha HD, Thong MX, et al. (2000) A randomized controlled comparison of azithromycin and ofloxacin for treatment of multidrug-resistant or nalidixic acid-resistant enteric fever. Antimicrob Agents Chemother 44: 1855-1859.
35. Butler T, Sridhar CB, Daga MK, Pathak K, Pandit RB, et al. (1999) Treatment of typhoid fever with azithromycin versus chloramphenicol in a randomized multicentre trial in India. J Antimicrob Chemother 44: 243-250.
36. Girgis NI, Butler T, Frenck RW, Sultan Y, Brown FM, et al. (1999) Azithromycin versus ciprofloxacin for treatment of uncomplicated typhoid fever in a randomized trial in Egypt that included patients with multidrug resistance. Antimicrob Agents Chemother 43: 1441-1444.
37. Capoor MR, Rawat D, Nair D, Hasan AS, Deb M, et al. (2007) In vitro activity of azithromycin, newer quinolones and cephalosporins in ciprofloxacin-resistant Salmonella causing enteric fever. J Med Microbiol 56: 1490-1494.
38. Gunell M, Kotilainen P, Jalava J, Huovinen P, Siitonen A, et al. (2010) In vitro activity of azithromycin against nontyphoidal Salmonella enterica. Antimicrob Agents Chemother 54: 3498-3501.
39. Molloy A, Nair S, Cooke FJ, Wain J, Farrington M, et al. (2010) First report of Salmonella enterica serotype paratyphi A azithromycin resistance leading to treatment failure. J Clin Microbiol 48: 4655-4657.
40. Phuc Nguyen MC, Woerther PL, Bouvet M, Andremont A, Leclercq R, et al. (2009) Escherichia coli as reservoir for macrolide resistance genes. Emerg Infect Dis 15: 1648-1650 10.3201/eid1510.090696 [doi].
41. [Anonymous] (2011) GARP Vietnam report: http://www.cddep.org/publications/situation_analysis_antibiotic_use_and_resistance_vietnam; accessed November 2nd, 2011.
42. Chiu CH, Su LH, Chu C, Chia JH, Wu TL, et al. (2004) Isolation of Salmonella enterica serotype choleraesuis resistant to ceftriaxone and ciprofloxacin. Lancet 363: 1285-1286 10.1016/S0140-6736(04)16003-0 [doi];S0140673604160030 [pii].
43. Su LH, Teng WS, Chen CL, Lee HY, Li HC, et al. (2011) Increasing ceftriaxone resistance in Salmonellae, Taiwan. Emerg Infect Dis 17: 1086-1090 10.3201/eid/1706.101949 [doi].
44. Vlieghe E, Phe T, De Smet B, Engchhun H, Kham C, Lynen L, et al. (2011) Bloodstream Infection among Cambodian Adults: Key Pathogens and Resistance Patterns. Abstract presented at the 51th ICAAC, September 18-21 2011, Chicago, US.